These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clonal spread of carbapenem resistant Acinetobacter baumannii in the patients and their environment at BMA Medical College and Vajira Hospital. Phumisantiphong U; Diraphat P; Utrarachkij F; Uaratanawong S; Siripanichgon K J Med Assoc Thai; 2009 Dec; 92 Suppl 7():S173-80. PubMed ID: 20232570 [TBL] [Abstract][Full Text] [Related]
4. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007. McCracken M; DeCorby M; Fuller J; Loo V; Hoban DJ; Zhanel GG; Mulvey MR J Antimicrob Chemother; 2009 Sep; 64(3):552-5. PubMed ID: 19578083 [TBL] [Abstract][Full Text] [Related]
5. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of patients infected with carbapenem-resistant Acinetobacter baumannii treated with single or combination antibiotic therapy. Santimaleeworagun W; Wongpoowarak P; Chayakul P; Pattharachayakul S; Tansakul P; Garey KW J Med Assoc Thai; 2011 Jul; 94(7):863-70. PubMed ID: 21774295 [TBL] [Abstract][Full Text] [Related]
7. Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates. Kiratisin P; Apisarnthanarak A; Kaewdaeng S Int J Antimicrob Agents; 2010 Sep; 36(3):243-6. PubMed ID: 20541913 [TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii strains in intensive care units of multiple Mediterranean hospitals. Giannouli M; Tomasone F; Agodi A; Vahaboglu H; Daoud Z; Triassi M; Tsakris A; Zarrilli R J Antimicrob Chemother; 2009 Apr; 63(4):828-30. PubMed ID: 19223304 [No Abstract] [Full Text] [Related]
9. An overview of antimicrobial susceptibility patterns for gram-negative bacteria from the National Antimicrobial Resistance Surveillance Thailand (NARST) program from 2000 to 2005. Apisarnthanarak A; Buppunharun W; Tiengrim S; Sawanpanyalert P; Aswapokee N J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S91-4. PubMed ID: 21298849 [TBL] [Abstract][Full Text] [Related]
10. CHROMagar Acinetobacter is not selective for carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex. Akers KS; Barsoumian A; Beckius ML; Murray CK; Mende K Diagn Microbiol Infect Dis; 2010 Jun; 67(2):209-11. PubMed ID: 20466197 [No Abstract] [Full Text] [Related]
11. Trends in antimicrobial resistance of Acinetobacter baumannii clinical isolates from hospitalised patients in Greece and treatment implications. Falagas ME; Mourtzoukou EG; Polemis M; Vatopoulos AC; Clin Microbiol Infect; 2007 Aug; 13(8):816-9. PubMed ID: 17610601 [TBL] [Abstract][Full Text] [Related]
13. Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England. Coelho JM; Turton JF; Kaufmann ME; Glover J; Woodford N; Warner M; Palepou MF; Pike R; Pitt TL; Patel BC; Livermore DM J Clin Microbiol; 2006 Oct; 44(10):3623-7. PubMed ID: 17021090 [TBL] [Abstract][Full Text] [Related]
14. National Antimicrobial Resistance Surveillance, Thailand (NARST) data among clinical isolates of Pseudomonas aeruginosa in Thailand from 2000 to 2005. Dejsirilert S; Suankratay C; Trakulsomboon S; Thongmali O; Sawanpanyalert P; Aswapokee N; Tantisiriwat W J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S68-75. PubMed ID: 21298847 [TBL] [Abstract][Full Text] [Related]
15. Mutant prevention concentration of tigecycline for carbapenem-susceptible and -resistant Acinetobacter baumannii. Cui JC; Liu YN; Chen LA J Antibiot (Tokyo); 2010 Jan; 63(1):29-31. PubMed ID: 19911030 [No Abstract] [Full Text] [Related]
16. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Poirel L; Nordmann P Clin Microbiol Infect; 2006 Sep; 12(9):826-36. PubMed ID: 16882287 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of antibiotic resistance among Acinetobacter baumannii isolates from Aleppo, Syria. Hamzeh AR; Al Najjar M; Mahfoud M Am J Infect Control; 2012 Oct; 40(8):776-7. PubMed ID: 22305413 [TBL] [Abstract][Full Text] [Related]
19. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit. Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588 [TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates. Seifert H; Stefanik D; Wisplinghoff H J Antimicrob Chemother; 2006 Nov; 58(5):1099-100. PubMed ID: 16980293 [No Abstract] [Full Text] [Related] [Next] [New Search]